300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Big Data
Photography
Email
Cryptocurrency
Digital Media
Artificial Intelligence
Non Profit
Clean Energy
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
InsurTech
Platforms
Film
Oil and Gas
Retail
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Sports
Education
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Blockchain
Software
Theatre
Beauty
Fashion
Infrastructure
Medical
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Web3
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Recruiting
FinTech
Social Media
Franchise
Internet
Android
Mobile Advertising
Impact
Proptech
Hardware
Transportation
Biotech
Enterprise
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Costa Rica
Armenia
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
New Zealand
Jamaica
Sri Lanka
Guatemala
Kazakhstan
Switzerland
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
South Africa
Paraguay
France
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Senegal
Portugal
Germany
India
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Angola
Europe
Barbados
Belgium
Cyprus
Austria
Ethiopia
Qatar
Jordan
Azerbaijan
Ecuador
Bahamas
Bulgaria
Bahrain
Bolivia
Jersey
Estonia
Belize
Algeria
Belarus
Hungary
Finland
Grenada
Israel
Honduras
Lithuania
Italy
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Vietnam
Ukraine
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Kern Whelan Capital, VC Fund

Kern Whelan Capital

VC Fund

San Francisco, United States

Kern Whelan Capital is a VC fund in San Francisco focused on Mobile and Software. Kern Whelan Capital manages a diversified investment portfolio stretching from new ventures to established and profitable businesses across many industry sectors. They invest in only a few companies each year, and partner with outstanding management teams for the long term. While they typically are active members of the board of directors for theirbusinesses, they do not seek involvement in their daily operations. Through a long term approach to the liquidity horizon, Kern Whelan investments are not beholden to a single exit strategy, but are instead opportunistic about investor capital return whether through M&A, IPO, recap, dividend, or otherwise.Investment ApproachThey back strong management teams in companies that generate, or have the potential to generate, operating profit margins of 15% or better. They look for a history of internal growth in a capital efficient manner with good prospects for future growth. They remain opportunistic investors, however, and will not rule out any opportunity with strong cash flow potential. They prefer simple capital structures so that their interests are more closely aligned with management. As Kern Whelan principals they demonstrate their commitment to the success of their investors, management and business by typically serving as the largest personal investors in each of their portfolio companies.

Total investments:
3
Last investment:
Lead investor:
33%

Last updated:

Industries Kern Whelan Capital invests in

MobileSoftwareBiotechnology

Stages Kern Whelan Capital invests in

Series BSeries C

Countries Kern Whelan Capital invests in

AustraliaUnited States

Contacts

NameEmailPhoneSocials
Jay Kern Jay Kern

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Mobile 1 (33%)
  • Software 1 (33%)
  • Biotechnology 1 (33%)

Stage

  • Series B 2 (67%)
  • Series C 1 (33%)

Country

  • Australia 1 (33%)
  • United States 1 (33%)

Team

NameTitleInvestmentsLinksEmail
Jay Kern
Jay Kern Founder and General Partner
Founder and General Partner Total investments: 2
Find email

Investments

CompanyDescriptionRoundLinks
GPN Vaccines GPN Vaccines
GPN Vaccines are a type of vaccine that is used to prevent the spread developing a vaccine against streptococcus pneumoniae. $12M / Series B / Jun 06, 2024
Quri Quri
Quri is a retail intelligence company that provides instant visibility into the performance of products and promotions in retail stores. Quri enables brands and retailers to measure and optimize the exact shopper experience, maximizing in-store product revenue and profitability. Quri is powered by a nationwide, on-demand mobile field force ofsecret shoppers who can be immediately deployed to any retail location in the U.S., providing real-time actionable data and insights to brands and retailers. $17M / Series C / Oct 14, 2015
Cohera Medical Cohera Medical
Cohera Medical is a medical device company that is actively developing a line of surgical adhesives and sealants. Its products are based on a unique chemical design that is resorbable, non-toxic, easy-to-use and forms a strong bond between tissue layers. The company's lead product, TissuGlu® Surgical Adhesive, is indicated for use in theU.S. for the approximation of tissue planes in abdominoplasty procedures. TissuGlu is currently approved for sale in the EU for the approximation of tissue layers where subcutaneous dead space exists between the tissue planes in large flap surgical procedures such as abdominoplasty and is being utilized in Europe to eliminate drains or reduce complications in patients undergoing large flaps surgical procedures such as abdominoplasty, mastectomy, lymph node dissection, decubitus, and latissimus dorsi flap procedures. Its second product under development, Sylys® Surgical Sealant, the first synthetic sealant designed specifically to help reduce anastomotic leaks, has received CE Mark approval in Europe as an adjunct to standard closure in ileostomy reversal procedures. TissuGlu and Sylys are the first products in a pipeline of technology that includes surgical mesh adhesives, hemostatic foam, bone adhesives, and drug delivery. Sylys and the other Cohera Medical products are currently available for investigational use only and have not yet been approved for sale by the Food and Drug Administration (FDA) in the U.S. or in any other market. Series B

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Big Data
Photography
Email
Cryptocurrency
Digital Media
Artificial Intelligence
Non Profit
Clean Energy
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
InsurTech
Platforms
Film
Oil and Gas
Retail
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Sports
Education
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Blockchain
Software
Theatre
Beauty
Fashion
Infrastructure
Medical
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Web3
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Recruiting
FinTech
Social Media
Franchise
Internet
Android
Mobile Advertising
Impact
Proptech
Hardware
Transportation
Biotech
Enterprise
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Costa Rica
Armenia
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
New Zealand
Jamaica
Sri Lanka
Guatemala
Kazakhstan
Switzerland
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
South Africa
Paraguay
France
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Senegal
Portugal
Germany
India
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Angola
Europe
Barbados
Belgium
Cyprus
Austria
Ethiopia
Qatar
Jordan
Azerbaijan
Ecuador
Bahamas
Bulgaria
Bahrain
Bolivia
Jersey
Estonia
Belize
Algeria
Belarus
Hungary
Finland
Grenada
Israel
Honduras
Lithuania
Italy
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Vietnam
Ukraine
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Kern Whelan Capital invest in?

Kern Whelan Capital invests primarily in Mobile, Software and Biotechnology startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Kern Whelan Capital?

Public channels for Kern Whelan Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Kern Whelan Capital?

The team at Kern Whelan Capital includes Jay Kern (Founder and General Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Kern Whelan Capital Kern Whelan Capital Find emails